Integra LifeSciences Reports Fourth Quarter 2013 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Integra Lifesciences Holdings (IART) Misses Q4 EPS by 3c
February 25, 2014 6:36 AM ESTIntegra Lifesciences Holdings (NASDAQ: IART) reported Q4 EPS of $0.78, $0.03 worse than the analyst estimate of $0.81. Revenue for the quarter came in at $220.8 million versus the consensus estimate of $223.37 million.
Integra Lifesciences Holdings sees FY2014 revenue of $920-940 million, versus the consensus of $932.3 million.... More
